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Certain immediate hypersensitivity reactions depend upon the union of anti- 
gen with specific antibody "fixed" on the surface of target cells. This interaction 
starts an enzymatic sequence leading to release of pharmacologically active sub- 
stances from the sensitized ceils or a fluid phase substrate (1-3). These agents 
(histamine, serotonin, SRS-A, and kinins) in turn increase vascular permeability 
and/or constrict smooth muscles, contributing to a clinical phenomenon known 
as  "anaphylaxis." The homologous immunoglobnlln~ which  mediate passive 
cutaneous or systemic anaphylaxis in certain species have been characterized 
(4, 5), and in the guinea pig and rat the immunoglobulin which sensitizes guinea 
pig or rat mast cells, respectively, for antigen-induced release of histamine has 
been identified (6-8). 
Slow  reacting  substance  of anaphylaxis  is  an  acidic  material  of unknown 
chemical composition  (9).  Its  pharmacological effects include  the  ability  to 
constrict smooth muscle of the guinea pig ileum, human bronchiole, and rabbit 
duodenum in the presence of an antihistamine; and the inability to act on the 
estrous rat uterus preparation (9). SRS-A is released into the incubation fluid 
following the exposure of sensitized gtfinea pig, rabbit, or human (10) lung tissue 
to antigen. Unlike histamine, which is set free from preexistent stores by certain 
antigen-antibody interactions, SRS-A is detected only after sensitized tissue is 
challenged with antigen, indicating that it is present in a precursor form prior 
to antigen-antibody interaction. The term "release" is used in this communica- 
tion in place of the more accurate but cumbersome "formation and release" of 
SRS-A. 
* This investigation  was supported by Grant No. AI-04536 from the National Institute of 
Allergy and Infectious Disease, Grant No. AM-3564 from the National Tnstitute of Arthritis 
and Metabolic Diseases, and a grant from the American Cancer Society,  Inc. (Massachusetts 
Division). 
Recipient of a USPHS Postdoctoral Research FeUows]fip  from the National Institute of 
Arthritis and Metabolic Diseases. 
§ Senior  Investigator, Arthritis Foundation. 
127 128  ANTIBODIES INVOLVED IN RELEASE OF  SRS-A 
Limited information is available concerning the mechanism of release of slow 
reacting substance of anaphylaxis (SRS-A) from guinea pig lung slices (11, 12). 
Rapp demonstrated that SRS-A was released into the peritoneal cavity of rats 
injected with hyperimmune rabbit antisera followed, after a  latent period, by 
challenge with antigen (13). In these experiments, little or no release of hista- 
mine was observed. Mota has shown  that mast cells were not altered by ex- 
posure to rabbit antiserum and subsequent  challenge with antigen (14).  It is 
also known that the release of histamine from rat mast cells can be effected by 
antisera containing  homocytotropic antibody,  ~ but  not  by hyper~mmune  rat 
antisera  (14,  15).  The possibility therefore existed that different homologous 
immunoglobulins might mediate the release of different pharmacological agents 
in a  single species of animals. The present studies were undertaken to identify 
the guinea pig and rat antibodies involved in the release of SRS-A and to com- 
pare them with the homologous immunoglobulins mediating histamine release 
in these species. 
Materials and Methods 
Preparation of Antigen.--Bovine serum albumin (BSA) and egg albumin (~,a) (5 times re- 
crystallized) were supplied by Pentex, Inc., Kankakee, Ill. 
Dinitrophenyl bovine "/-globulin  (DNP-BTG),  dinitrophenyl bovine fibrinogen  (DNP- 
fibrinogen), and dinitrophenyl bovine serum albumin (DNP-BSA) were prepared as previously 
described  (18); DNP-B~'G contained  40 and DNP-BSA 18 haptenic groups/mole of protein. 
Nippostrongylus brasiliensis larvae were supplied by Dr. R. J. M. Wilson of the Harvard 
School of Tropical Medicine. Adult worms were obtained from the small intestine of rats 10 
days following a primary infection with 3000-5000 larvae admini.~tered subcutaneously (19). 
The soluble extract obtained by grinding 1000 adult worms in 1.0 ml saline in a tissue grinder 
was used  to challenge rats following intradermal (passive cutaneous  anaphylaxis, PCA) or 
intraperitoneal injections of antiserum or isolated antiserum fractions. 
Preparation of Antisera.--Gulnea  pig anfi-DNP antisera were obtained from animals hyper- 
immunized  with DNP-B~gG emulsified in complete Freund's adjuvant (Difco  Laboratories, 
Inc., Detroit, Mich.)  (20). Antisera were subjected to starch block electrophoresis  (20), and 
"/a- and 5'~-regions  were identified by immunoelectrophoresis and by the serological properties 
of 5'x- and T~-antibodies (4, 21). 
Rabbit antibovine serum album~n (Ra anti-BSA) antisera were obtained from albino rabbits 
injected in the toe pads with 2.5 rag of BSA emulsified in complete Freund's adjuvant. 3 
months later, each rabbit received 6 mg of alum-precipitated BSA intravenously every other 
day for a 1 week period, and serum was obtained 7-10 days after the last injection. 
1 The term "homocytotropic antibody" has been proposed  (16, 17) as a replacement for 
"mast cell-sensitizing" (6) or  "anaphylactic" antibody (5). Redefinition is neceessry because 
the systemic or cutaneous reactions termed "anaphylactic" arise by various different immuno- 
logical mechanisms and do not necessarily involve the mast cell or histamine release. It has 
therefore been suggested that the term "anaphylactic" be restricted to a description of in vivo 
reactions.  "Homocytotropic antibody" will be used in this paper to describe a unique homol- 
ogous immunogiobulin capable of sensitizing host mast cells for release of histamine upon con- 
tact with antigen; the existence of other homocytotropic antibodies,  capable of sensitizing 
other target cells and/or mediating the release of other mediators, is considered likely. D.  J.  STECHSCHuLTE~  K.  F.  AUSTEN~ AND  K.  J.  BLOCH  129 
Sprague-Dawley rats were injected in the footpads and intraperitoneally with an emulsion 
consisting of 0.5 ml of DNP-BTG (2 mg/ml) and 0.5 ml of complete Freund's adjuvant. 10 
and 20 days later the animals were boosted subcutaneously and intraperitoneally with a  total 
of 1 nag of antigen emuLsified in complete Freund's adjuvant. On day 27, the rats were injected 
intradermally at two sites with 0.1  ml of antigen solution (1 mg/ml); these injections were 
repeated every 7 days until a definite Arthus reaction was obtained. "Hyperlmmune" antisera 
were collected 35--45 days after initial immnni~-~tion. 
Antisera containing homocytotropic antibody were obtained  from rats injected in each 
footpad with 0.3 ml of a mixture containing 3 nag of DNP-BTG and 2 X  109 Bordetella pertus- 
s/s organisms  2 per ml, and the rats were exsanguinated 7-10 days later.  Antisera containing 
high concentrations of homocytotropic antibody directed against worm antigens were obtained 
from rats 7-10 days after a second injection with 3000-5000  N. brasiliensis larvae. The larvae 
were administered to these animals 20 or 30 days after their primary infection. 
Determination of Antibody ConcenJration.--The antibody concentration of various antisera 
was determined by precipitin analysis (5, 22). Rabbit anti-BSA antisera contained 4.0-6.5 mg 
antibody protein per ml; rat antisera contained 0.5 to 1.6 mg antihapten antibody per nil. 
Passive hemagglutination, passive immune hemolysis, and complement fixation tests were 
performed as previously described (21). 
Passive  Cutaneous Anapkylaxis.--Pa~ve  cutaneous  mmphylaxis was  performed  as de- 
scribed (23). Intraeutaneous injections of 0.1 ml aliquots of serial dilutions of homologous anti- 
serum or antiserum fractions were made into the shaved backs of albino guinea pigs weighing 
approximately 300 g. 4 hr later, the anlm~ls were injected intravenously with 1 ml of solution 
cont~inlng 1 nag of antigen in 0.5% Evans' blue dye. The reactions were read 30 rain later, and 
the diameters of the blue spots recorded. Titers are expressed as the reciprocal of the final 
dilution fielding a positive reaction measuring 10 mm in diameter. All reactions were performed 
in triplicate, and no more than 16 sites were injected per animal. 
Male Sprague-Dawley rats weighing 150-200 g wereinjected in the skin of the back with 0.1 
ml volumes of various dilutions of antiserum or antiserum fractions. After a latent period of 
4 or 48 hr, they were injected intravenously with 1 ml of a solution containing 1 mg of antigen 
or 0.2 ml of worm extract in 0.5% Evans' blue dye. 45 min after the injection of antigen, the 
rats were killed and .~lclnned,  and the underside of the skin was e~rarnlned for the presence 
and extent of blueing. Results are recorded as described above. 
Purification  and Fractionation of Rat Ant/sera.--Rat  anti-DNP antibodies were isolated 
according to method II of Eisen (24) with slight modifications. After decomplementing rat 
antiserum with a heterolngons antibody-antigen system at equivalence, antibodies were pre- 
cipitated with DNP.fibdnogen; the resulting antigen-antibedy complexes were dissociated with 
DNP+L-Iysine. Excess hapten was subsequently removed from the antibody solution by pro- 
longed dialysis against buffered saline. 
Preparative starch block eiectrophoresis was performed as described (20, 25). The starting 
material consisted of the globulin fraction obtained by 500-/0 saturation with (NHa)sSO4  of 30 
ml of rat anti-DNP antiserum  (pool D, containing 1.1 mg of antibody protein per ml). Fol- 
lowing electrophoresis, the starch block was cut into 1 cm strips, and the proteins contained 
in each strip were eluted by displacement filtration. After dialysis against phosphate buffer at 
0.001 x, pH 7.4, fractions were lyophilized and subsequently resnspended in 1.0 ml saline.Pro- 
tein determinations were made by a  modified Folin-Ciocalten method  (26).  Prior to  intra- 
peritoneal injection, each fraction was dialyzed against Tyrode's solution (gincose-free)  for 3 
hr. 
Chromatography on DEAE-celiulose columns was performed using either sequential (27) or 
s We are indebted to Dr. Irving Millman of Merck Sharp and Dohme for the heat-killed 
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gradient (28) elution with slight modifications.  4-8 ml of antiserum or the globulin fraction 
from 14 ml of antiserum was applied to columns 2.2 cm in diameter and 35 cm in length; sequen- 
tial elution was performed with three phosphate buffers: 0.01 M, pH 7.5; 0.02 %  pH 6.2; and 
0.05 %  pH 5.0. The amount of each buffer applied was equal to 1.5 times the void volume of 
the column. 4 ml samples were collected at the rate of approximately 0.7 ml per cain. The pro- 
tein concentration of the eluates was determined by spectrophotometry at 2800 A; protein 
peaks were combined and concentrated by ultrafaltration at 4°C. The concentrated samples were 
tested by immunoelectrophoresis and PCA in the rat,  as well as for their ability to release 
SRS-A in the rat. Almost all of the rat TG-globulin was present in the first peak, labeled a, 
but trace amounts were distributed throughout the subsequent eluates. The rat globulin iden- 
tiffed asqtA (29) was not detected until phosphate buffer 0.05 M, pH 5.0,  was applied;  this 
buffer also eluted homocytotropic antibody. ~/M-globulin  was not eluted with these buffers. 
Gradient elution was performed by gradually combining 500 ml of phosphate buffer 0.01 ~t, 
pH 7.5, with 500 ml of phosphate buffer 0.I % pH 5, in 500 ml Erlenmeyer flasks. The rate of 
elution, pattern obtained, and processing of eluates were the same as described above. 
Immunode.cteophoresis.--lmmunoelectrophoretic  analysis  was  performed  according  to  a 
modification (4) of the method of Scheidegger (30). Lantern slides (3J,~ X 4 inches) were coated 
with 1% agar in a barbital buffer, pH 8.6, ionic strength 0.075. Whole antiserum or antiserum 
fractious were subjected to electrophoresis at 15 ma and 200 v/slide  for 120 rain. Predpitin lines 
were developed with rabbit antisera  to guinea pig or rat immunoglobuling. These antisera 
were obtained from rabbits  immunized with antigen-antibody complexes according to the 
method of Arnason, de Vaux St.-Cyr, and Relyveld (29). Antiserum specific for rat IgA was 
prepared as described (29). By using constant amounts of antisera in both the center wells and 
troughs of the immunoelectrophoresis plate, it was possible to grade arbitrarily on a scale of 
0--4-t- the relative immunoglobulin content of a  sample. 
Bioassay of Histamine and SRS-A.--I=Ylstamine was assayed on the standard isolated guinea 
pig ileum preparation in the presence of 10  -~ M atropine. Recorded values, representing the 
average quantity of histamine released in at least two replicate experiments, were determined 
by the closed-bracket assay technique comparing unknown samples with standard histamine 
base  solutious.  Values  are  corrected for  spontaneous  histamine release observed in control 
samples. 
Slow reacting substance of anaphylaxis was assayed on the standard guinea pig ileum prep- 
aration which had been treated with atropine and mepyramine maleate  a at a concentration of 
10  -4 M in order to abolish the histamine response.  Recorded values represent the average 
number of SRS-A units released in two or more replicate experiments. The SRS-A assay was 
calibrated using a standard  SRS-A sample supplied by Dr. W. E. Brocklehurst; 1 unit refers 
to a  characteristic contraction of the guinea pig ileum equal in amplitude to approximately 
5 m#g of histamine. Since the peritoneal fluid (obtained as described below) must be used for 
several different biologlcal assays,  it is necessary to dilute the original sample 5-fold. As a re- 
stilt, more than 15 units of SRS-A (5 units/m]) must be present in the original sample in order 
to be detected. 
All samples of peritoneal fluid were assayed for the presence of klnlnS and serotonin using 
the estrous rat uterus (31, 32). 
Sen~tisation  of Perfused, Sliced G~inea Pig Lung.--Gninea pigs weighing approximately 
300 g served as a source of lung tissue. The tissue was perfused, washed, sliced, and passively 
sensitized in vitro with 7S'y1 and 7S3'~ guinea pig antibody as previously described (7). 
Preparation of Rats for SRS-A  Release.--Male  Sprague-Dawley rats weighing 150-400  g 
were injected intraperitoneally with antiserum or antiserum fractions. Only rats of approxi- 
s Kindly supplied by Mr. R. C. Anderson of Merck Sharp and Dolune. D.  J.  STECHSCHULTE,  K.  F.  AUSTEN, AND  K.  ~.  BLOCH  131 
mately equal weight were used in a single experiment. 4-6 hr later, antigen, together with 250 
#g of heparin in 5 ml of Tyrode's solution, was introduced by the same route. Exactly 5 mlu 
later, the rats were killed by a blow to the head, and peritoneal fluid was collected. The peri- 
toneal cells were separated by centrifugation at 175 g for 10 min at 4°C. The supematant fluid 
was immediately assayed for its SRS-A, histamine, serotouin, and lrlnln content or was stored 
at --70°C. The histamine content of peritoneal cells was determined after extraction of hista- 
mine by boi|in~ in sealed test tubes for 10 rain in 3 ml of physiological saline solution. 
RESULTS 
In Vitro Release of SRS-A from Guinea Pig Lung 
Preliminary  experiments indicated that  guinea pig lung  tissue exposed in 
vitro to guinea pig anti-DNP antisera and later challenged with antigen released 
both histamine and SRS-A.  In order to identify the class of irnmunoglobulln 
responsible for mediating this reaction, guinea pig antisera were subjected to 
starch block electropboresis. Both the immunoelectropborefic and serological 
properties of eluates obtained from the starch block were used to identify the 
~/1- and 3,rregious.  Thus, the ability of eluted fractious to sensitize  guinea pigs 
for PCA reactions was used to locate the "),rantibody region, and the ability to 
sensitize  antigen-coated, tannic acid-treated erythrocytes for lysis in the pres- 
ence of complement, or to fix complement in the presence of antigen  (in the 
Ea-anti-Ea system), was used to locate the T,-antibody region. 
Results obtained with a  fractionated guinea pig anti-DNP  antiserum  are 
presented in Fig. 1. Fractions 17-21, containing primarily "yx-antibodies, were 
combined, as were fractious 9-13, containing primarily T2-antibodies.  Guinea 
pig lung tissue exposed to "yx-anti-DNP antibodies and challenged with antigen 
after a 2 hr interval released 3 #g of histamine (18% of total histamine available 
in the lung slices) and 600 units of SRS-A per g of wet lung. Tissue exposed to 
%-antibodies failed to release  either histamine or SRS-A.  Similar  results were 
obtained with isolated guinea pig 3'x- and ~,r-anti-Ea antibody fractious. 
In Vivo Rdease of SRS-A from Rat Tissue 
Experiments  Involving Rabbit Antiserum.--Rats  weighing  250-300  g  were 
injected intraperitoneally with an aliquot of rabbit anti-BSA antiserum con- 
mining 2.5 nag of antibody protein. 4 hr later, 2 mg of BSA was injected intra- 
peritoneally. Under these conditions, 200-300 units of SRS-A were found in the 
peritoneal fluid obtained 5  mln  after challenge  with  antigen.  Doubling the 
quantity of antigen or antibody injected did not increase the yield of SRS-A. 
In subsequent experiments, antigen was injected 15 mill and 1, 3, 6, 9,  15, 
24, and 48 hr after the administration of antiserum.  Three or four rats were 
injected at each time interval. Maximum release of SRS-A was obtained after 
an interval of 3 hr and was maintained up to 9 hr; gradual decline in the yield 
of SRS-A occurred when the interval exceeded 9 hr. After a 48 hr interval, the 
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4-fold increase in the quantity of either antigen or antibody failed to shorten 
the 3 hr interval required to obtain maximum release of SRS-A. The histamine 
content of the peritoneal fluids in these experiments  was minimal, 0.25 #g or 
less.  4 These results indicated that, under the conditions employed, hyperimmune 
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FIO. 1. Comparison of SRS-A and histamine  release from sliced guinea  pig lung  sensi- 
tized with either 7S3'1  or 7S3"2-guinea  pig antibodies separated by starch block electrophoresis. 
Each division of the right ordinate is equal to 0.02 OD unit (26). 
rabbit antiserum prepared rat tissue for the release of SRS-A, rather than hista- 
mine. 
4 Although the histamine content of cells in the peritoneal fluid was determined in all experi- 
ments and ranged from 15 to 45/~g (increasing with the size of rats used), the amount of hista- 
mine released in the fluid is not expressed as a precentage of this value, since other sources of 
histamine exist in the peritoneal cavity. In each experiment the total cen histamine in control 
and experimental animals was similar, indicating  that antiserum  adm;n;stration  per se had 
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Experiments Involving Hyperimmune Rat Antiserum.-- 
El~ect on SRS-A release of varying the dose of rat antibody: Rats were injected 
intraperitoneally with aliquots of rat anti-DNP antiserum containing 0.2-3.5 
mg of antihapten antibody protein. 4  hr later, 2 mg of antigen, DNP-BSA, 
was administered, and 5 mln later, peritoneal fluid was recovered and assayed 
for SRS-A. It was found that at least 0.5 nag of antibody protein was required 
to release measurable quantities of SRS-A in some animals; 1 mg of antibody 
protein consistently yielded measurable amounts of SRS-A in all animals tested. 
A 2.5 nag dose of antibody protein increased the release of SRS-A by approxi- 
mately 40 %; a further increase of antibody protein to 3.5 mg did not enhance 
the release of SRS-A. In order to conserve antibody, subsequent experiments 
TABLE  I 
Rdease of SRS-A from Rat Tissue Exposed to Different Pools of Ityperimmune Rat Antiserum* 
Rat anti-DNP-B'yG 
antiserum 
Pool A 
Pool B 
Pool C 
PCA titer~;  Histamine releas~ 
#g/rat 
0.15  4-  0.09 
0.30 4- 0.1 
O.lO 4- 0.07 
SRS-A release§ 
unlts/rat 
320  4-  120 
1250  ±  600 
450  4-  120 
* 1  nag of precipitating antibody protein was injected intraperitoneally,  and 4  hr later 
2 nag of DNP-BSA was administered by the same route. 
Rats challenged after a  48 hr latent period. 
§ Mean value and 1 s, from seven or more experiments. 
were performed using 1.0 mg precipitating rat antibody protein per test ani- 
mal. 
Three different pools of hyperimmune rat anti-DNP antisera were compared 
at constant antibody doses for their ability to prepare rats for SRS-A release. 
These antisera were free of homocytotropic antibody as determined by a nega- 
tive PCA reaction in the rat after a 48 hr latent period. The results of at least 
seven separate experiments with each pool are summarized in Table L  The 
average number of SRS-A units released per rat varied from 320 units for pool 
A to 1250 units for pool B. Histamine release was negligible in all instances, and 
only trace amounts of kinin  (less than 0.001  /zg/ml)  or serotonin  (less than 
0.005 pg/ml) were detected. These results indicated that SRS-A was the major 
pharmacological agent released under the experimental conditions tested. 
EffecJ on SRS-A release of varying the dose of antigen: Antiserum pools B and 
C  were used to study the effect of various doses of antigen on the release of 
SRS-A from rat tissues. Four to six rats were injected intrapefitoneally with 
1.0 mg antihapten antibody protein, followed, after an interval of 4-5 hr, by 134  ANTIBODIES INVOLVED IN RELEASE OF SRS-A 
selected amounts of antigen. Rats injected with antibody from pool B received 
0.5-4.0 mg DNP-BSA antigen; those injected with antibody from pool C  re- 
ceived 0.1--4.0 mg antigen. As indicated in Fig. 2, 2.0 mg of antigen produced 
optimal release of SRS-A from tissue treated with either antiserum pool B or C, 
although the total amount of SRS-A released by antiserum pool B  was con- 
siderably greater. 
Effect on SRS-A release of varying the time of exposure of rat tisssue to rat anti- 
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Fro. 2. Effect on SRS-A release of varying the dose of antigen. 
serum: 2 mg of antigen was injected intraperitoneally 15 mln to 20 hr after the 
administration  of 1.0  mg antibody protein from antiserum pool A  (Fig.  3). 
Four rats  were  tested at  each  time interval.  Optimal release of SRS-A  was 
obtained by injecting antigen 1-9 hr after administration of antiserum. Injec- 
tion of antigen at 15 rain or 20 hr yielded considerably less SRS-A: 18% and 
30%, respectively, of the optimal values obtained. In contrast to rabbit anti- 
serum, homologous antiserum prepared rat tissue for optimal release of SRS-A 
during a  1 hr rather than a 3 hr interval. 
The relationship between release of histamine and SRS-A in the course of D.  J.  STECHSCHULTE~  K.  ~.  AUSTEN~  AND  K.  J.  BLOCH  135 
these experiments is presented in Fig. 4. The release of histamine was 9 times 
greater after an interval of 15 mln than after an interval of 1 hr, whereas the 
release of SRS-A was greater (330 units) after 1 hr compared to the release at 
15 mln (60 units). These results suggest that different mechanisms axe involved 
in the release of these two pharmacological agents from rat tissues by hyper- 
immune rat antiserum and specific antigen. 
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FIG. 3. Effect on SRS-A release of varying the time of exposure  of rat peritoneal tissue to 
rat anti-DNP antiserum. 2 mg of antigen was used in the experiments  depicted in Figs. 3-8. 
Experiments Involving Fractionated Rat Antiserum.-- 
Electrophoret~c separation of rat immunoglobulins: The globulin fraction of rat 
antiserum pool D  was subjected to electrophoresis on a  starch block; eluted 
fractions were tested as illustrated in Fig. 5. The relative amounts of the three 
rat immunoglobul~ns were estimated by immunoelectrophoresis; the peak con- 
centration of rat ,yG-globulin was present in fractions 14-17, the peak of "yA 
was present in fractions 18-22, and the peak concentration of "yYl-globulin was 
distributed about the zone of application of protein to the starch block. Aliquots 
of each concentrated fraction (0.7  ml) were tested for their ability to prepare 
rats for the release of SRS-A. Rats injected with fractions 14-20 released SRS-A 
upon challenge with antigen; the peak activity, 1200-2400 unlts/rat, was found 136  ANTIBODIES  INVOLVED  IN  RELEASE  OF  SRS-A 
in fractions 16-18. Thus, SRS-A release did not coincide with the peak concen- 
tration of any of the three known rat immunoglobulins. Although trace amounts 
of histamine were apparently released by antibodies present in several fractions, 
somewhat  greater release  (as  much as  0.4  #g/rat)  was  obtained with  those 
fractions which also produced release of SRS-A. 
Chromatographic  separation  of  rat  immunoglobulins  on  DEAE-cdtulose 
columns:  Chromatography of rat  antiserum  on DEAE-cellulose columns  re- 
sulted in a more complete separation of rat immunoglobulins G and A. Columns 
1 and 2 were each loaded with aliquots of antiserum pool D containing approxi- 
mately 4.0 mg anti-DNP antibody protein. The profiles of protein concentration 
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FIG. 4. Effect on SRS-A and histamine release of varying the time of exposure  of rat peri- 
toneal tissue to rat anti-DNP antiserum. 
in eluates from these columns were very similar; for this reason an average of 
the two curves is shown in Fig. 6. The peaks of protein eluted with phosphate 
buffer 0.01  ~, pH 7.5, were combined, as were the peaks obtained with phos- 
phate buffer 0.05 •,  pH 5.0. Onimmunoelectrophoresis, the former  contained  only 
"yG, and the latter contained primarily -rA-globulins. Rats were injected intra- 
peritoneally with aliquots of these two peaks and subsequently chaUenged with 
antigen.  A  moderate  amount  of  SRS-A  (58  units/rat)  was  released  in  rats 
treated with the "yG-containing peak; no SRS-A was released in rats treated 
with the "yA-containing peak. Histamine release was negligible with both frac- 
tions. 
Purified anti-DNP antibody obtained from 30 ml of pool D  antiserum was 
applied to DEAE-cellulose column 6; two small peaks of protein concentration, 
a  and b,  were eluted  (Fig.  7).  On immunoelectrophoresis, pooled fractions a 
contained  "¢G-antibodies,  and  pooled  fractions  b  contained  "rA-antibodies. D.  J.  STF.CHSCHULTF.~  K.  ]~.  AUSTEN,  AND  K.  ~.  ]3LOCH  137 
Passive  hemagglutination  revealed comparable  antibody  titers  in  a  and  b: 
1/10,240 and 1/5,120. Aliquots of a released 300 units of SRS-A and 3.8 #g of 
histamine per rat; aliquots of b failed to prepare rats for the release of either 
SRS-A  or histamine. 
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titer at 48 hr, 0) and 4 ml of anti-DNP antiserum obtained 10 days after im- 
munization with a DNP-B~,G and B. pertgssis mixture (PCA titer at 48 hr, 1/ 
80), was separated by DEAE-cellulose chromatography on column 14 (Fig. 8). 
Eluates were combined as indicated. On immunoelectrophoresis pooled frac- 
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DNP antiserum (pool E) on column 14. 
tions a and b contained ~G-globulins, and pooled fractions c and d contained 
primarily "yA-globullns.  Aliquots of each were injected intradermaUy into a 
group of rats. Some ~Lnlmals  were injected with antigen after 4 hr, and others 
after 48 hr. Dermal blueing was observed at sites injected with pooled fractions 
a in animals challenged after a 4 hr interval; this reaction was barely elicited 140  ANTIBODIES  INVOLVED  IN  RELEASE  O~"  SRS-A 
after 48 hr.  Positive reactions were also observed at skin sites injected with 
pooled fractions c after a latent period of both 4 and 48 hr. These results indicate 
that homocytotropic antibody was eluted with proteins constituting peak c. 
Aliquots  were also used  to prepare rats  for the  release of SRS-A.  Pooled 
fractions a mediated the release of 675 units of SRS-A and 1.5 #g of histamine, 
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FIG.  9.  SRS-A and histamine release with pooled eluates containing ~/G- and "yA-globulins, 
as well as homocytotropic antibody obtained by DEAE-cellulose chromatography of rat anti- 
N. bras//iots/s antiserum (pool 4) on column 12. 
pooled fractions b mediated the release of 20 units of SRS-A and 1.1 #g of hista- 
mine, and pooled fractions c produced 249 units of SRS-A and 2.6 #g of hista- 
mine per rat. A small amount of both agents was released in rats injected with 
pooled fractions d. The ratio of SRS-A to histamlne-releasing activity of a was 
almost 5 times greater than that of c. Thus, despite the presence of homocyto- 
tropic antibody in  the  eluates  from column  14,  the  major  SRS-A-releasing 
activity continued to be associated with the ~/G-contalning fractions. 
The effect of relatively large amounts of homocytotropic antibody on the 
release  of  SRS-A  was  further  tested  using  eluates  from  a  DEAE-ceUulose D.  J.  STECHSCHULTE~  K.  F.  AUSTEN~  AND  K.  J'.  BLOCH  141 
column  loaded  with  the  giobulln  fraction  obtained  from  14  ml  of anti-N. 
brasiliensis  antiserum pool 4  (PCA titer at 48 hr,  1/300). Eluates were com- 
bined as shown in Fig. 9. On ;mmunoelectrophoresis  pooled fractions a, b, and c 
contained ~,G-globullns; pooled fractions d and e contained primarily ~,A-globu- 
lins.  PCA reactions were elicited only after a  48 hr latent period at sites in- 
jected with aliquots of d and e, indicating the presence of homocytotropic anti- 
body in these fractions. Pooled fractions a, b, and c failed to prepare rat tissue 
for the release  of either SRS-A or histamine, presumably because of the low 
concentration of "rG anti-N,  brasiliensis  antibodies present in the antiserum 
pool employed. Pooled fractions c and d mediated the release of 3.3 and 2.4 #g 
of hist,mine per rat and only 15 and 30 units of SRS-A, respectively. Serotonin 
was also released following  sensitization  with homocytotropic antibody; the 
ratio of histamine to serotonin released was 10-20:1. The results demonstrate 
that  homocytotropic antibody was capable of sensitizing  mast  cells  for the 
release  of histamine and serotonin.  These same fractions mediated the release 
of small amounts of SRS-A. 
DISCUSSION 
Earlier studies have established that guinea pig ~'x-, but not "Yr, antibodies 
mediate passive cutaneous and systemic anaphylaxis and sensitize  guinea pig 
lung tissue in vitro for antigen-induced release of histamine. The present study 
has defined an additional function of ~/1-antibodies in the guinea pig, i.e. media- 
tion of the release  of SRS-A (Fig.  1). Indirect evidence suggests that guinea 
pig "yrantibodies become attached or "fixed" to host mast cells so that sub- 
sequent contact with antigen leads to the release  of various pharmacological 
agents (4, 7). Whether the mast cell is the source of SRS-A in the guinea pig is 
not established. Release of histamine from certain sensitized  guinea pig tissues 
was always accompanied by the release  of SRS-A (10,  11), and Austen and 
Brocklehurst,  using a  variety of enhancing  and inhibiting  substances, never 
observed changes in yield of histamine or of SRS-A independently of the other 
(12). Although these data are compatible with the view that both substances 
arise from the same cell, it is also possible that both are liberated from different 
cells by the union of antigen with 5'l-antibodies  on the surface of the respective 
cells. 
Rabbit anti-BSA antiserum prepared rat  tissue for the release  of SRS-A, 
and little or no histamine was released into the peritoneal cavity under experi- 
mental conditions leading  to optimal release  of SRS-A.  The immunoglobuiin 
class of the rabbit antibodies involved in this reaction was not identified; how- 
ever, the immunization  schedule used generally results in the production of 
"yG-antibodies. 
A  latent period of several hours was required between injection of rabbit 
antiserum and challenge  with antigen.  This interval may be required for the 142  ANTIBODIES  INVOLVED  IN  RELEASE  0]~  SRS-A 
diffusion of antiserum to critical sites on tissue, or it may represent the interval 
needed for antiserum to become "fixed" on a target cell which is the source of 
SRS-A. 
Hyperimmune rat anfisermn also prepared rat tissue for the release of SRS-A, 
accompanied by minimal release of histamine  (Table I  and Figs. 2-4). Experi- 
ments performed with antiserum fractions obtained by DEAE-cellulose chroma- 
tography indicated  that  antibodies  with properties of "yG-globulins were pri- 
marily involved in the release of SRS-A (Figs. 6-8).  On starch block electro- 
pboresis  (Fig.  5),  the peak of SRS-A-releasing activity migrated  faster than 
the bulk of "tG-globulins.  The latter  observation may indicate  that  SRS-A- 
releasing  activity  is  a  function  of  electrophoretically  "fast"  migrating  ~G- 
antibodies or that specific rat "rG--anti-DNP antibodies migrate "faster" than 
the bulk of nonspecific "rG-globulins (33). 
Rats injected with constant amounts of precipitating antibody from different 
antiserum  pools were found to differ considerably in  the quantity of SRS-A 
released  (Table I). This finding suggests the possibility that SRS-A-releasing 
activity is not a function of the precipitating  antibody but may instead be a 
function of an unidentified subclass of "rG-globulins. However, the three anti- 
serum pools were not tested simultaneously on a single group of rats, and it is 
therefore possible that differences in sensitivity of the animals may account for 
the  results  observed. It is also possible that  the antiserum  pools differed in 
their avidity for antigen. 
A  latent  period  was required  for the optimal  release of SRS-A by hyper- 
immune  rat  antiserum.  The  latent  period  with  homologous  antiserum  was 
shorter  than  that  required  with  heterologous  antiserum;  the  reason for this 
disparity is unknown. The demonstration of a latent period (Fig. 3) again sug- 
gests the possibility that rat ~rG-antibodies may be "sensitizing" a  target cell 
for the release of SRS-A upon contact with antigen. It is unlikely that the target 
ceil involved is the rat mast cell, since there is considerable evidence that hyper- 
immune rabbit and rat antisera  do not sensitize rat mast ceils. Rats actively 
immunized  so  as  to  achieve high  titers  of circulating  antibody  consistently 
became prostrate following intravenous injections of specific antigen; yet, when 
the mesenteries  of these animals  were incubated  with  specific antigen,  there 
was no detectable histamine  release  (15,  34). Rats injected intravenously or 
intraperitoneally  with rabbit or rat hyperimmune antiserum and subsequently 
challenged with antigen administered intravenously also undergo a shock reac- 
tion; however, examination of their tissues revealed their mast cells to be intact, 
and no histamine was released into the plasma during the course of the reaction 
(14). Rat mesentery or diaphragm  exposed in vitro to rabbit antiserum failed 
to show mast cell damage or histamine release on exposure to antigen (14). In 
view of these observations, it is unlikely that rabbit or rat hyperimmune anti- 
sera mediate the release of SRS-A via sensitization of rat mast ceils. D.  J.  STECHSCHU'LTE)  K.  ~.  AUSTEN)  AND  K.  J.  BLOCH  143 
In  the present  experiments  antiserum  fractions  from the ~/A-region, con- 
taining homocytotropic antibody, sensitized  the peritoneal tissues for histamine 
release, accompanied by n~nlmal (Fig. 9) to moderate (Fig. 8) release of SRS-A. 
In  the  experiment  shown in  Fig.  8,  fractions  from the 7A-region mediated 
considerable histamine release and only moderate SRS-A release, while fractions 
from the 7G-region directed against the same antigenic determinant prepared 
rat tissue for the release of large amounts of SRS-A and moderate amounts of 
histamine.  The  association  of histamine  release,  in  the  relative  absence of 
SRS-A release, with material from the 7A-region is particularly well illustrated 
by Fig. 9. Although the homocytotropic antibodies which sensitize for histamine 
release are associated with the ~/A-region, absorption experiments  with rabbit 
anti-rat ~,A have indicated that homocytotropic antibody is not a ~/A-globulin 
(8). 
It is evident that the rat 7G-globulin or a subfraction thereof, which prepares 
an unidentified target cell or tissue in the rat peritoneal cavity for release  of 
SRS-A upon contact with antigen, is distinctly different from the rat immuno- 
globulin) homocytotropic antibody, which sensitizes rat mast cells for histamine 
release.  In preparing rat tissue for SRS-A release,  the rat 7G-globulin or sub- 
fraction thereof may be acting as a second type of homocytotropic antibody. 
Although histamine  release  was not observed in rats prepared  with whole 
hypefimmune rabbit or rat antiserum and challenged with antigen after several 
hours, histamine release  was observed if the latent period was brief (Fig. 4). 
On the other hand, varying histamine release did occur under routine conditions 
when the rats were prepared with ^/G-fractions  (Figs. 5-8). Since ~¢G-antibodies 
do not sensitize mast cells for the release of histamine, other mechanisms must 
be responsible for the release of histamine observed. One such mechanism may 
involve the formation of hlstamlne-releasing  agents by rat ~,G-antibody--anti- 
gen-complement aggregates (35). 
In conclusion, it now appears to be possible to distinguish at least two differ- 
ent mechanisms  capable of producing the immediate  hypersensitivity lesion, 
termed PCA, in the rat. Homocytotropic antibody provokes passive cutaneous 
anaphylaYi.q by sensitizing  rat mast cells for release of histamine and serotonin 
upon contact with antigen. PCA reactions elicited in this manner may be in- 
hibited  by antihistamine  and  antiserotonin  agents  (36);  the optimal  latent 
period for this PCA reaction is 24-72 hr (5, 36). 
A clinically identical reaction may be elicited in the rat following intradermal 
injection of rabbit or rat hyperlmmune antiserum,  or 7G-fractions,  followed 
by intravenous injection of antigen in 4 but not 24 hr. This reaction is not sup- 
pressed by antihistamine  or antiserotonin  agents  (37)  and  does not involve 
mast cell degranulation  (14).  Whether it represents a  single  phenomenon or 
several different ones is uncertain; at least three associated factors have now 
been recognized.  First,  the intensity of the lesion  can be correlated to some 144  ANTIBODIES  INVOLVED  IN  RELEASE  OF  SRS-A 
extent with the level of serum complement activity (38). Second, the reaction 
can be suppressed  by rendering  rats leukopenic  (39). The latter observation 
prompted Lovett and Movat (39) to speculate that formation of microprecipi- 
tates of antigen and antibody, followed by phagocytosis  of the aggregates  by 
polymorphonuclear  leukocytes  and release of their lysosomal  enzymes,  was 
responsible for the changein capillary permeability. Finally, homologous hyper- 
immune antiserum or its "~,G-fraction  has been shown  to mediate release of 
SRS-A from rat tissue. The interrelationship of these  three factors and their 
role in producing  PCA lesions provoked with hyper~mmune serum in the rat 
remains to be further assessed. 
Preliminary studies were performed to evaluate the possible effect of SRS-A 
on vascular permeability. Peritoneal fluid containing large amounts of SRS-A 
and negligible concentrations of histamine, serotonin,  and kinin were injected 
into the shaved dorsal skin of albino guinea pigs just prior to intravenous ad- 
ministration of Evans' blue dye. Blueing was observed in a dose-response fash- 
ion and could not be attributed to the cumulative action of trace amounts of 
other mediators; however, the contribution of soluble complexes could not be 
assessed. Any definite conclusion as to the role of SRS-A in increasing vascular 
permeability must be deferred until the pure material is available  for study. 
SUMMARY 
The antigen-induced release  of SRS-A and histamine was studied in the 
guinea pig and rat using whole and fracfionated antiserum preparations. 
Guinea pig 7S'yrantibody sensitized sliced guinea pig lung tissue for antigen- 
induced release of both SRS-A and histamine; neither substance was released 
from lung tissue prepared with 7S'y,-antibody. 
Rats injected intraperitoneally with hyperimmune rabbit or rat antiserum 
released only SRS-A in significant amounts when challenged with antigen by 
the same route. A definite time interval between the injection of antiserum and 
challenge with antigen was required for optimal release of SRS-A. 
Fractionation of rat antiserum demonstrated that the immunoglobulin  re- 
sponsible for most of the SRS-A release from rat peritoneal tissue  was a ~tG- 
antibody or fraction thereof.  Acting in this capacity, the "gG-anfibody or its 
subfraction may be  considered  a  second  type of homocytotropic antibody. 
Fractions of rat antisera containing the first type of homocytotropic antibody, 
i.e. antibody mediating release of histamine and serotonin, prepared peritoneal 
tissues  for the release of large amounts of these pharmacological  agents and 
only small amounts of SRS-A. 
Two different mechanisms for the production of PCA lesions in the rat were 
considered. One of these involves the antigen-induced release of histamine and 
serotonin from mast cells sensitized by homocytotropic antibody. This reaction 
has an optimal latent period of 24-72 hr. The second mechanism involves the D.  J.  STECHSCHULTE, K.  F.  AUSTEI~, AND K.  J.  BLOCH  145 
local combination of antigen with "hyperimmtme" heterologous or homologous 
anfisera. This reaction can be elicited after a latent period of 4 but not 24 hr; 
host complement and leukocyte lysosomal enzymes, as well as SRS-A, may be 
involved. 
We acknowledge with gratitude  the expert, untiring technical assistance given by Miss 
Barbara Moyer. 
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